Epione Labs Private Limited

Research-driven pharmaceutical product development services for global markets, including formulation, analytical research, and regulatory affairs.

2012 | Rangareddy, Telangana (India) | Active
Last Updated: December 11, 2024

Epione Labs Profile

Key Indicators

  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 2.78 Cr
  • Company Age 12 Year, 7 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 11.37 Cr
  • Revenue Growth -61.15%
  • Profit Growth -15.31%
  • Ebitda -7.69%
  • Net Worth -47.86%
  • Total Assets -28.64%

About Epione Labs

Epione Labs Private Limited (ELPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2012 and has a history of 12 years and seven months. Its registered office is in Rangareddy, Telangana, India.

The Corporate was formerly known as Sankramana Life Sciences Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.78 Cr.

The company has closed loans amounting to ₹11.37 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Sirish Ravula, Haritha Ravula, Bandoju Srinivas, and One other member serve as directors at the Company.

Company Details

  • Location

    Rangareddy, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232TG2012PTC081598

  • Company No.

    081598

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Jun 2012

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

What products or services does Epione Labs Private Limited offer?

Epione Labs Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Company Law & Labour Law Consultants, Statutory Compliance Services.

Who are the key members and board of directors at Epione Labs?

Board Members (4)

Name Designation Appointment Date Status
Sirish Ravula Country flag representing In Director 11-May-2020 Current
Haritha Ravula Country flag representing In Director 30-Jan-2017 Current
Bandoju Srinivas Country flag representing In Director 31-May-2022 Current
Bolloju Brahmanandam Country flag representing In Additional Director 30-Mar-2023 Current

Financial Performance of Epione Labs.

Epione Labs Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.15% decrease. The company also saw a substantial fall in profitability, with a 15.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 47.86%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-61.15%
Revenue from Operations
-62.30%
Total Assets
-28.64%
Profit or Loss
-15.31%
Net Worth
-47.86%
EBITDA
-7.69%

What is the Ownership and Shareholding Structure of Epione Labs?

In 2022, Epione Labs had a promoter holding of 35.54% and a public holding of 64.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹11.37 Cr

Charges Breakdown by Lending Institutions

  • Others : 6.00 Cr
  • Ap State Financial Corporation : 4.25 Cr
  • Axis Bank Limited : 1.12 Cr

Latest Charge Details

Date Lender Amount Status
21 Aug 2020 Axis Bank Limited ₹5.66 M Satisfied
21 Aug 2020 Axis Bank Limited ₹5.52 M Satisfied
10 Oct 2017 Others ₹6.00 Cr Satisfied
17 Jun 2014 Ap State Financial Corporation ₹4.25 Cr Satisfied

How Many Employees Work at Epione Labs?

Epione Labs has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Epione Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epione Labs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Epione Labs

Recent activity within the organization

  • Director Appointment

    Bolloju Veera Venkata Brahmanandam was appointed as a Additional Director was appointed as a Additional Director on 30 Mar 2023 & has been associated with this company since 1 year 10 months .

    30 Mar 2023

  • Annual General Meeting

    Epione Labs Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Director Appointment

    Bandoju Srinivas was appointed as a Director was appointed as a Director on 31 May 2022 & has been associated with this company since 2 years 8 months .

    31 May 2022

  • Balance Sheet

    Epione Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.

    31 Mar 2022

  • Charges

    A charge registered on 21 Aug 2020 via Charge ID 100413141 with Axis Bank Limited was fully satisfied on 29 Dec 2021.

    29 Dec 2021

  • Charges

    A charge registered on 21 Aug 2020 via Charge ID 100413146 with Axis Bank Limited was fully satisfied on 29 Dec 2021.

    29 Dec 2021

Frequently asked questions

  • Epione Labs Private Limited was incorporated on 21 Jun 2012.

  • The authorized share capital of Epione Labs Private Limited is ₹ 4.00 Cr and paid-up capital is ₹ 2.78 Cr.

  • Currently 4 directors are associated with Epione Labs Private Limited.

    • Sirish Kumar Ravula
    • Haritha Ravula
    • Bandoju Srinivas
    • Bolloju Veera Venkata Brahmanandam
  • As per Ministry of Corporate Affairs (Mca), the registered address of Epione Labs Private Limited is Building 900 Park, Genome Valley Shamirpet Mandal India, Hyderabad, Telangana, 500076.

  • The corporate identification number (CIN) of Epione Labs Private Limited is U24232TG2012PTC081598 and the company number is 081598 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Epione Labs Private Limited is https://www.epionelabs.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Epione Labs Private Limited has fallen by -61.15%.

  • As Per 2021 financial reports, 7 employees are currently employed by Epione Labs Private Limited.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Epione Labs Private Limited has experienced an downturn of -47.86%.

  • The most recent Balance Sheet for Epione Labs Private Limited was filed with the ROC on 31 Mar 2022.

Similar Companies Based on Pharma Contract R&D